DHX15 acts as a cancer promoter in breast cancer, prostate cancer, acute myeloid leukemia, and hepatocellular carcinoma (HCC), and as an antitumor factor in glioma due to its growth inhibitory function [12,13,14,15,16]. This evidence concerns the gene DHX15 and central nervous system cancer.